Title
Diagnostic accuracy of dried blood spots for serology of vaccine-preventable diseases: a systematic review
Date Issued
01 January 2022
Access level
open access
Resource Type
review
Author(s)
Holroyd T.A.
Chang R.H.
Wanyiri J.W.
Saldanha I.J.
Gross M.
Moss W.J.
Hayford K.
Johns Hopkins Bloomberg School of Public Health
Publisher(s)
Taylor and Francis Ltd.
Abstract
Introduction: Venous serum and plasma are optimal specimens for serological testing but may be logistically infeasible. Dried blood spots (DBS) are a feasible alternative, provided results are adequately sensitive and specific. We aimed to assess the diagnostic accuracy of DBS to measure IgG and IgM antibodies for vaccine-preventable diseases and compare test validity of DBS with venous blood. Areas covered: In October 2020, we searched seven databases for peer-reviewed studies assessing the diagnostic accuracy of DBS specimens compared with serum in detecting antibodies to VPDs in humans. We extracted data and assessed risk of bias in all included studies. We calculated sensitivity and specificity with 95% confidence intervals for each index-reference test comparison. We narratively synthesized the identified evidence on diagnostic accuracy and blood collection and processing methods for DBS. Studies on measles and rubella IgG and IgM were the most frequently identified and reported generally high sensitivity and specificity. Expert opinion: Lack of standardization in collection, storage, and testing methods limited systematic comparison across studies. Our findings indicate a need for additional validation studies on the diagnostic accuracy of DBS to expand their use in serological surveillance. We recommend practical considerations to improve standardized reporting for DBS validation studies.
Start page
185
End page
200
Volume
21
Issue
2
Language
English
OCDE Knowledge area
Enfermedades infecciosas Epidemiología Salud pública, Salud ambiental
Scopus EID
2-s2.0-85122881850
PubMed ID
Source
Expert Review of Vaccines
ISSN of the container
14760584
Sponsor(s)
Bill and Melinda Gates Foundation - OPP1094816 -BMGF For this systematic review was provided by the Bill & Melinda Gates Foundation (grant number OPP1094816). FS was supported by FONDECYT-CONCYTEC (grant contract number 246–2015-FONDECYT). This article is dedicated to Sara Lowther, PhD, MPH, who inspired the original work. We would like to thank the following data extractors for their dedicated work in the systematic review process: Mallory Trent, MSPH, Purnima Ravisankar, MHS, Saranya Seetharaman, MPH, and Amie Park, MHS. We would also like to thank Greer Waldrop, MD, ScM for her involvement in the preliminary planning stages. The results of this manuscript were previously presented as an abstract at the Annual Conference on Vaccine Research, Bethesda, MD (virtual conference) in April 2020.
Sources of information: Directorio de Producción Científica Scopus